Current:Home > reviewsWhy does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers. -Edge Finance Strategies
Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers.
View
Date:2025-04-17 13:16:48
Senators grilled the top executive of Novo Nordisk over why the Danish company charges Americans far more for the blockbuster weight-loss drug Wegovy and diabetes drug Ozempic than it does patients in Europe.
Novo Nordisk CEO Lars Fruergaard Jørgensen appeared before the Senate Committee on Health, Education, Labor and Pensions. The committee is chaired by Sen. Bernie Sanders, a Vermont independent who launched an investigation this year into Novo Nordisk's drug pricing.
Novo Nordisk has made nearly $50 billion on the sales of Ozempic and Wegovy since 2018, Sanders said. He described the U.S. as a "cash cow" for Novo Nordisk, accounting for 72% of the company's worldwide sales of those two drugs.
Among questions posed by Sanders: Why do Americans pay far more for these medications than patients in other countries?
Sanders opened the hearing by displaying charts comparing Novo Nordisk's prices charged to Americans and Europeans. The company charges U.S. residents $969 a month for Ozempic, but the same drug costs $155 in Canada, $122 in Denmark, and $59 in Germany.
For the weight-loss drug Wegovy, Americans pay $1,349 a month. The drug can be purchased for $186 in Denmark, $140 in Germany, and $92 in the United Kingdom, according to Sanders' charts.
"Nobody here is asking Novo Nordisk to provide charity to the American people," Sanders said. "All we are saying, Mr. Jørgensen, is treat the American people the same way that you treat people all over the world. Stop ripping us off."
Jørgensen defended the company's pricing of the wildly popular medications and said 80% of Americans can get these drugs for $25 or less per month.
He said U.S. list prices can't be compared to prices charged in other countries, in part, due to the nation's complex structure. U.S. prices are influenced by health insurance companies and drug-pricing middlemen called pharmacy benefit managers.
Jørgensen said the diabetes drug Ozempic is covered by the vast majority of private health insurance plans, as well as Medicare and Medicaid, the government health insurance programs for seniors and low-income families. Wegovy is covered by about half of private health insurers, Medicaid plans in 20 states and the Department of Veterans Affairs.
"You have said that our amazing medicines can't help patients if they can't afford them ‒ that is true," Jørgensen said. "It is also true that the full value of Ozempic and Wegovy can only be realized if patients can access them. Patients need affordability and access."
Medicare, the federal health program for adults 65 and older, is prohibited by law from covering drugs for those who are obese but otherwise do not have serious risk factors. But obese patients with diabetes or heart disease may qualify for coverage. The nonprofit health policy organization KFF estimated that 1 in 4 Medicare enrollees who are obese may be eligible for Wegovy to reduce their risk of heart attack or stroke.
The committee also highlighted a March study from researchers at Yale University found these drugs could be made for less than $5 a month, or $57 per year. Last week, Sanders announced CEOs of major generic pharmaceutical companies would be willing to sell Ozempic to Americans for less than $100 per month, at a profit. However, such estimates do not account for the expensive costs of researching and developing drugs and testing them in clinical trials.
Jørgensen said Novo Nordisk scientists have worked on the weight-loss drugs since the early 1990s. The company also has committed $30 billion to expand manufacturing capacity to address supply shortages of the medications.
Representatives of drug industry's trade group PhRMA said health insurers and pharmacy benefit managers deserve more scrutiny when it comes to drug affordability.
“The one question everyone should be asking is why aren’t insurers and PBMs being forced to answer for denying coverage and driving up patients’ costs?" said Alex Schriver, senior vice president of public affairs at PhRMA: "Senator Sanders continues repeating the same misleading rhetoric on drug prices. But why won’t he talk about how insurance conglomerates are taking in record profits or how PBMs are being investigated and sued for their abusive tactics?"
veryGood! (836)
Related
- Meta donates $1 million to Trump’s inauguration fund
- Tyler Christopher, General Hospital and Days of Our Lives actor, dies at 50
- Utah teen found dead in family's corn maze with rope around neck after apparent accident
- Hawaii couple who gained attention for posing in KGB uniforms convicted of stealing identities of dead babies
- Charges tied to China weigh on GM in Q4, but profit and revenue top expectations
- NFL hot seat rankings: Which coaches could be fired after Raiders dropped Josh McDaniels?
- Daniel Radcliffe’s Stunt Double Recalls Harry Potter Accident That Left Him Paralyzed
- Central Michigan investigating if Connor Stalions was on sideline for Michigan State game
- Selena Gomez engaged to Benny Blanco after 1 year together: 'Forever begins now'
- Natalee Holloway’s confessed killer returns to Peru to serve out sentence in another murder
Ranking
- Jamie Foxx reps say actor was hit in face by a glass at birthday dinner, needed stitches
- Israel criticizes South American countries after they cut diplomatic ties and recall ambassadors
- Chiefs TE Travis Kelce still smarting over upset loss to Broncos: 'That's embarrassing'
- 80-foot Norway spruce gets the nod as Rockefeller Center Christmas tree, will be cut down next week
- New Mexico governor seeks funding to recycle fracking water, expand preschool, treat mental health
- A Bunch of Celebs Dressed Like Barbie and Ken For Halloween 2023 and, Yes, it Was Fantastic
- Escalating violence threatens Day of the Dead celebrations in Mexico’s northern Sonora state
- Model Athenna Crosby Speaks Out About Final Meeting With Matthew Perry One Day Before His Death
Recommendation
Woman dies after Singapore family of 3 gets into accident in Taiwan
Pentagon UFO office launches digital form to collect info on government UAP programs, activities
Connecticut officer charged with assault after stun gunning accused beer thief
New Jersey governor spent $12K on stadium events, including a Taylor Swift concert
A South Texas lawmaker’s 15
Louisiana was open to Cancer Alley concessions. Then EPA dropped its investigation
Where Dorit Kemsley's Marriage Really Stands After Slamming Divorce Rumors
Central Michigan investigating if Connor Stalions was on sideline for Michigan State game